NCT05911295 Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05898256 Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05877911 Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy Status UNKNOWN Phase PHASE2
NCT05870319 A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05862168 Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma :A Single-arm, Prospective, Phase II Trial Status RECRUITING Phase PHASE2
NCT05857631 Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study Status RECRUITING Phase NA
NCT05854849 Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC Status RECRUITING Phase PHASE3
NCT05828381 Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05827523 Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04) Status RECRUITING Phase PHASE3
NCT05821556 Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients Status RECRUITING Phase PHASE2
NCT05821452 Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT05821192 Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma. Status UNKNOWN Phase NA
NCT05819892 Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer Status RECRUITING Phase PHASE1
NCT05813626 Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05800574 Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer Status RECRUITING Phase PHASE2
NCT05800054 Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer Status RECRUITING Phase NA
NCT05800015 A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05799469 Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05798819 A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT05791097 Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC. Status WITHDRAWN Phase PHASE3